At a Glance
- Recent 13F filings for the Q1 2025 reporting period show that 14 hedge funds held Bristol Myers Squibb Co. (BMY).
- Analysis of these filings reveals shifts in BMY holdings among these funds compared to the previous quarter.
- While individual filings offer limited insight (due to only long positions being disclosed), aggregate data can be more revealing.
- Between Q4 2024 and Q1 2025, hedge funds collectively increased their BMY holdings by approximately 1.53%, adding over 1 million shares.
Hedge Fund Activity in Bristol Myers Squibb (BMY)
Holdings Channel has analyzed the latest batch of 13F filings, covering the reporting period ending March 31, 2025. During this period, Bristol Myers Squibb Co. (BMY) was a holding in 14 of the reviewed filings. When a significant number of fund managers appear to be making similar investment decisions, it can warrant a closer look.
It’s crucial to remember that 13F filings exclusively disclose long positions with the SEC. Short positions, including complex strategies like shorting call options, are not reported. This means a fund might show a long position in BMY within a 13F filing, potentially signaling a bullish stance, while simultaneously holding a bearish position that remains undisclosed.
Despite this limitation, examining groups of 13F filings over time can offer valuable insights, particularly when comparing changes from one reporting period to the next. The most recent filings provide an opportunity to observe how hedge fund managers adjusted their positions in BMY.
Shifts in BMY Holdings
Within the analyzed batch for the March 31, 2025 reporting period, 3 funds reported increasing their existing BMY positions compared to the December 31, 2024 period. Conversely, 8 funds reduced their holdings. Notably, Fairway Wealth LLC, included in this recent filing group, fully exited its position in BMY common stock as of March 31, 2025.
Aggregate Hedge Fund Sentiment Towards BMY
Moving beyond this specific subset of filings, a broader look at the aggregate BMY share count across all hedge funds holding the stock as of March 31, 2025 (out of a total of 2,392 funds reviewed) provides a more comprehensive picture. Comparing this to the aggregate share count held by the same funds on December 31, 2024, reveals an overall increase in hedge fund holdings of BMY.
Between these two reporting periods, funds increased their aggregate BMY holdings by 1,065,848 shares. This brings the total number of shares held by these funds to 70,551,232, up from 69,485,384. This represents an approximate 1.53% rise in the aggregate share count held by hedge funds.
Expert Summary
The analysis of recent 13F filings indicates a modest aggregate increase in hedge fund holdings of Bristol Myers Squibb (BMY) for the first quarter of 2025. While individual filings can present an incomplete view of a fund’s strategy, the collective data suggests a growing interest among institutional investors in BMY.